Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07149662
What this trial is testing

Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy

Who this might be right for
Multiple SclerosisPregnancy
Region Stockholm 111
Early research (Phase 1)UnknownNCT05003141
What this trial is testing

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

Who this might be right for
Follicular LymphomaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWaldenstrom Macroglobulinemia+5 more
Qilu Puget Sound Biotherapeutics (dba Sound Biologics) 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886139
What this trial is testing

TRS005 in Patients With CD20-positive R/R DLBCL.

Who this might be right for
CD20-positive Diffuse Large B-Cell Lymphoma
Zhejiang Teruisi Pharmaceutical Inc. 139
Testing effectiveness (Phase 2)Study completedNCT00005631
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00003595
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)WithdrawnNCT03169790
What this trial is testing

QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL

Who this might be right for
Non Hodgkin Lymphoma
ImmunityBio, Inc.
Early research (Phase 1)Active Not RecruitingNCT05797233
What this trial is testing

Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaB-Cell Chronic Lymphocytic LeukemiaLymphoma, B-Cell
National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Study completedNCT00003150
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 630
Testing effectiveness (Phase 2)Ended earlyNCT01397591
What this trial is testing

Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+2 more
OHSU Knight Cancer Institute 3
Testing effectiveness (Phase 2)UnknownNCT04425824
What this trial is testing

Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell LymphomaRituximabToripalimab
Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Early research (Phase 1)UnknownNCT03980379
What this trial is testing

Pharmacokinetics, Efficacy and Safety of the 304 Injection

Who this might be right for
CD20 Positive B Cell NHL
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Early research (Phase 1)Looking for participantsNCT07073833
What this trial is testing

The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Imbioray (Hangzhou) Biomedicine Co., Ltd. 40
Not applicableStudy completedNCT01479387
What this trial is testing

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)
Bayer 72
Testing effectiveness (Phase 2)UnknownNCT00397800
What this trial is testing

Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Technical University of Munich 12
Large-scale testing (Phase 3)Study completedNCT01459887
What this trial is testing

Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Shanghai CP Guojian Pharmaceutical Co., Ltd. 278
Large-scale testing (Phase 3)Looking for participantsNCT05045664
What this trial is testing

Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody

Who this might be right for
Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a
Heidelberg University 100
Early research (Phase 1)Temporarily pausedNCT07555561
What this trial is testing

Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

Who this might be right for
Relapsed/Refractory Central Nervous System LymphomaRelapsed/Refractory Primary Central Nervous System LymphomaRelapsed/Refractory Secondary Central Nervous System Lymphoma
Beijing Boren Hospital 30
Early research (Phase 1)Ended earlyNCT03670888
What this trial is testing

Compare the Bioequivalence and Safety of JHL1101 and Rituximab in CD20 Positive B Cell Lymphoma Patients

Who this might be right for
B Cell Lymphoma
JHL Biotech, Inc. 1
Early research (Phase 1)Ended earlyNCT06248086
What this trial is testing

Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas

Who this might be right for
B-cell Lymphoma
Astellas Pharma Global Development, Inc. 1
Next Page